Findings presented at the 2023 American Heart Association Scientific Symposium highlighted a pivotal study demonstrating validation of a noninvasive brachial cuff-ECG system for estimation of elevated left ventricular end diastolic pressure (LVEDP). The study provides the physician community with evidence that the Vivio^® device plays an important role in improving the ability to accurately and non-invasively detect elevated LVEDP.